(Q40168303)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315027%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Agonists of TRAIL death receptors induce myeloma cell apoptosis that is not prevented by cells of the bone marrow microenvironment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315027%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315027%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Peter I Croucher

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315027%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Robert Graham G Russell

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315027%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Locklin RM

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315027%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

22 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315027%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315027%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315027%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315027%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

805-812

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315027%20AND%20SRC:MED&resulttype=core&format=json

Upregulation of osteoblast apoptosis by malignant plasma cells: a role in myeloma bone disease

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404518

7 January 2021

TRAIL and its receptors as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404518

7 January 2021

Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma and other neoplasias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404518

7 January 2021

TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404518

7 January 2021

TRAIL-induced eradication of primary tumour cells from multiple myeloma patient bone marrows is not related to TRAIL receptor expression or prior chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404518

7 January 2021

TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404518

7 January 2021

Following a TRAIL: update on a ligand and its five receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404518

7 January 2021

Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404518

7 January 2021

Expression of TRAIL and TRAIL receptors in normal and malignant tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404518

7 January 2021

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404518

7 January 2021

Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404518

7 January 2021

A role of TRAIL in killing osteoblasts by myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404518

7 January 2021

A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404518

7 January 2021

Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404518

7 January 2021

Myeloma cells can directly contribute to the pool of RANKL in bone bypassing the classic stromal and osteoblast pathway of osteoclast stimulation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404518

7 January 2021

Immunocytochemistry reveals RANKL expression of myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404518

7 January 2021

Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404518

7 January 2021

Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404518

7 January 2021

Isotype-dependent inhibition of tumor growth in vivo by monoclonal antibodies to death receptor 4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404518

7 January 2021

Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404518

7 January 2021

Pharmacological manipulation of cell death: clinical applications in sight?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404518

7 January 2021

Mcl-1L cleavage is involved in TRAIL-R1- and TRAIL-R2-mediated apoptosis induced by HGS-ETR1 and HGS-ETR2 human mAbs in myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404518

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404518

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315027%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

26 December 2019

1037878404

0 references

1 reference